Oral Potassium Lowers Clinic BP in Untreated Hypertension; Ambulatory Effect Remains Uncertain
This meta-analysis of 19 short, mostly crossover trials quantifies the clinic and ambulatory blood pressure effect of potassium supplements in untreated primary hypertension and exposes how fragile that evidence is for pharmacist-led counseling.
📅 Journal publication: Nov 3, 2026(online Oct 30, 2026)·Last updated: Nov 16, 2026
Potassium supplements lower blood pressure in untreated hypertension.
Hypertension is a key risk factor for cardiovascular events, and managing blood pressure (BP) is essential in preventing these outcomes. Oral potassium reduced clinic systolic BP by 5.3 mm Hg and diastolic BP by 4.5 mm Hg in patients with untreated hypertension. While potassium supplementation could lower BP, the substantial heterogeneity and limited data on safety and ambulatory BP suggest cautious application. Oral potassium can modestly lower blood pressure in untreated hypertension, but further research is needed.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Citation:Ravichagua Ashiyama J, Medina FA, Loza C, et al. Oral Potassium Supplementation Lowers Clinic Blood Pressure in Untreated Primary Hypertension-Systematic Review and Meta-Analysis of Randomized Trials. Journal of the American Heart Association. 2026;15(21):e048590. doi:10.1161/JAHA.125.048590